Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
43.01
-0.19 (-0.44%)
At close: Feb 27, 2026
43.22% (1Y)
| Market Cap | 29.42B |
| Revenue (ttm) | 5.37B |
| Net Income (ttm) | 3.58B |
| Shares Out | 770.09M |
| EPS (ttm) | 4.66 |
| PE Ratio | 9.23 |
| Forward PE | 14.24 |
| Dividend | 1.28 (2.98%) |
| Ex-Dividend Date | Feb 12, 2026 |
| Volume | 2,797,027 |
| Average Volume | 5,672,277 |
| Open | 43.20 |
| Previous Close | 43.20 |
| Day's Range | 42.72 - 43.22 |
| 52-Week Range | 28.53 - 50.97 |
| Beta | 0.78 |
| RSI | 40.56 |
| Earnings Date | Mar 31, 2026 |